Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion Sanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the French drugmaker said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback